Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients

Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients

The occurrence of drug-induced osteonecrosis of the jaw in cancer patients treated using bone-modifying medications (bisphosphonates and denosumab) is a highly relevant research problem studied by dentists, maxillofacial surgeons, and oncologists. Despite the large number of publications, practical...

Full description

Saved in:
Bibliographic Details
Main Authors: E. M. Spevak, D. Yu. Christophorando, V. A. Shutov, A. V. Ermakova
Format: Article
Language:English
Published: Bashkir State Medical University 2022-07-01
Series:Креативная хирургия и онкология
Subjects:
bisphosphonate osteonecrosis of the jaw
bisphosphonates
denosumab
drug side effects
bone metabolism markers
malignant tumor
metastases
Online Access:https://www.surgonco.ru/jour/article/view/696
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.surgonco.ru/jour/article/view/696

Similar Items